Spain approves ‘dose-sparing’ of monkeypox vaccine | Inquirer News

Spain approves ‘dose-sparing’ of monkeypox vaccine

/ 01:14 PM August 23, 2022
Spain approves ‘dose-sparing’ of monkeypox vaccine

Two samples of suspected cases of monkeypox go through a process of nucleic acid extraction as they get tested at a microbiology lab at La Paz Hospital in Madrid, Spain, June 1, 2022. REUTERS FILE PHOTO

MADRID — Spanish health authorities on Monday approved a new monkeypox vaccination strategy, allowing more people to get vaccinated with smaller doses amid scarce supplies, the health ministry said in a statement.

Each dose of Bavarian Nordic’s Imvanex vaccine, the only monkeypox vaccine currently available, will be divided into five doses, with exceptions for pregnant women and immunocompromised people, the ministry said.

ADVERTISEMENT

With the new strategy, Spain follows in the footsteps of Britain, which also approved the use of smaller doses of the monkeypox vaccine on Monday, following the European Medicines Agency decision last week to allow “dose-sparing”.

On Monday, Spain received a further 5,000 doses of the vaccine, bringing the total received to more than 17,000 doses.

FEATURED STORIES

Spain is among the countries worst-hit by the disease, registering more than 6,119 monkeypox cases since May.

Worldwide, more than 40,000 cases have been reported in 80 non-endemic countries.

RELATED STORIES

Britain to pilot using smaller doses of monkeypox vaccine to boost supply

US authorizes monkeypox vaccine injection method to increase supply

US to get 36,000 more monkeypox vaccine doses this week, HHS says

PH working with US gov’t to secure monkeypox vaccines

Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Health, monkeypox, Spain
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.